*ST騰邦(300178.SZ):控股股東所持3080萬股將被司法拍賣
格隆匯5月6日丨 *ST騰邦(300178.SZ)公佈,公司於近日收到廣東省深圳市中級人民法院(“深圳中院”)《拍賣通知書》:控股股東騰邦集團與國信證券股份有限公司的證券糾紛案,深圳國際仲裁院(2019)深國仲裁5138號仲裁裁決已經發生法律效力。深圳中院將在京東網廣東省深圳市中級人民法院司法拍賣平台(網址:http://sifajd.com/2577)公開拍賣騰邦集團持有的公司股票(證券代碼:300178,證券性質:無限售流通股)3080萬股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.